Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
4.860
+0.010 (0.21%)
At close: Apr 28, 2026, 4:00 PM EDT
4.900
+0.040 (0.82%)
After-hours: Apr 28, 2026, 4:16 PM EDT
Absci Market Cap
Absci has a market cap or net worth of $743.68 million as of April 28, 2026. Its market cap has increased by 137.86% in one year.
Market Cap
743.68M
Enterprise Value
610.81M
1-Year Change
137.86%
Ranking
Category
Stock Price
$4.86
Market Cap Chart
Since the IPO on July 22, 2021, Absci's market cap has increased from $423.19M to $743.68M, an increase of 75.73%. That is a compound annual growth rate of 12.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 742.15M | 41.42% |
| Dec 31, 2025 | 524.80M | 74.40% |
| Dec 31, 2024 | 300.92M | -22.91% |
| Dec 29, 2023 | 390.34M | 101.18% |
| Dec 30, 2022 | 194.03M | -74.44% |
| Dec 31, 2021 | 759.25M | 79.41% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prime Medicine | 655.19M |
| First Tracks Biotherapeutics | 631.04M |
| Aclaris Therapeutics | 597.68M |
| Zevra Therapeutics | 595.88M |
| Adlai Nortye | 592.00M |
| ProKidney | 585.80M |
| Shattuck Labs | 585.00M |
| CorMedix | 581.94M |